Loading...
Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients
Hepatitis B virus (HBV) reactivation has been noted in HBV surface antigen (HBsAg)-seronegative patients with CD20(+) B-cell non-Hodgkin lymphoma (NHL) undergoing rituximab treatment. Clinically, hepatitis flares are usually associated with the reappearance of HBsAg (reverse seroconversion of HBsAg,...
Saved in:
| Published in: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Wolters Kluwer Health
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4839912/ https://ncbi.nlm.nih.gov/pubmed/26986131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000003064 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|